Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
03/26/2012
Trade Name:
Intelence
Generic or Proper Name (*):
etravirine
Indications Studied:
Treatment of HIV-1 infection in combination with other antiretroviral agents
Therapeutic Category:
Antiviral
Ages Studied:
6 - <18 years
Study #:
1
Study Type:
Safety/Pharmacokinetic
Study Design:
Open Label/Traditional Pharmacokinetic
No Patients:
20
No Centers:
20
No Countries:
5
Countries:
Spain, Germany, Italy, United Kingdom, United States
-
-